Thursday
SESSION 25: MISCELLANEOUS IMPORTANT TOPICS (4-MINUTE TALKS)
SESSION 25 SCHEDULE
THE CCSVI CONTROVERSY IN MULTIPLE SCLEROSIS
4:00 PM - 4:04 PM Creation Of A New IVC In A Patient Whose IVC Was Obliterated By Trauma: An Interventional Approach
  Presenter(s):Thomas A. Sos, MD / Akhilesh Sista, MD  
4:05 PM - 4:09 PM What’s Happening To The Randomized Trials Comparing Interventional Treatment To Placebo Treatment Of CCSVI In MS Patients
  Presenter(s):L. Nelson Hopkins, MD  
4:10 PM - 4:14 PM Incidence Of Internal Jugular Vein Stenosis In Thoracic Outlet Syndrome Patients: How Does This Relate To MS And CCSVI
  Presenter(s):Sam S. Ahn, MD, MBA, FACS  
4:15 PM - 4:19 PM Are Venous Anomalies In MS Patients Relevant Or Not
  Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh  
  View Abstract      
4:20 PM - 4:24 PM MS And CCSVI: Is The Relationship Real And Causally Important
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
  View Abstract      
4:25 PM - 4:29 PM Improving Contemporary Usage And Techniques Result In Better Patency With Nitinol SFA Stents (Smart Stents): Based On The STROLL Trial
  Presenter(s):Marc H. Glickman, MD  
MORE ABOUT ABDOMINAL AND THORACOABDOMINAL ANEURYSMS
4:30 PM - 4:34 PM New Classification Of Suprarenal Aneurysms Based On Location Of The Proximal Seal Zone: Correlates With Mortality And Morbidity Of Fenestrated And Branched Endografts
  Presenter(s):Krassi Ivancev, MD, PhD  
  View Abstract      
4:35 PM - 4:39 PM Is Medical Treatment To Slow Growth Of AAAs Effective: The STOPS Trial
  Presenter(s):Ronald L. Dalman, MD  
4:40 PM - 4:44 PM An Improved Method For Measuring AAA Size With EKG Gated 3D Ultrasound
  Presenter(s):Henrik Sillesen, MD, DMSc  
  View Abstract      
4:45 PM - 4:49 PM What Is The "Best" Treatment For Perigraft Hygroma With AAA Sac Enlargement After EVAR
  Presenter(s):John Blebea, MD, MBA  
4:50 PM - 4:54 PM Novel Method For Making Cannulation Of The Contralateral Limb Quick (<10 Seconds) And Easy During EVAR
  Presenter(s):Willem Wisselink, MD  
4:55 PM - 5:00 PM Panel Discussion
MISCELLANEOUS TOPICS
Moderator(s): John B. Chang, MD / Elliot L. Chaikof, MD, PhD  
5:01 PM - 5:05 PM What Will Happen In The Effort To Separate Doctors From Industry: Predictions For The Future And What Is Happening In Massachusetts
  Presenter(s):Richard A. Baum, MD, MPA, MBA  
5:06 PM - 5:10 PM Principles Of Medical Treatment To Prevent Stroke
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP, FRACP  
  View Abstract      
5:11 PM - 5:15 PM Managing Complications Of CAS
  Presenter(s):Klaus D. Mathias, MD  
5:16 PM - 5:20 PM Stroke Prevention And PFO Closure: Dead Or Alive
  Presenter(s):William A. Gray, MD  
5:21 PM - 5:25 PM Catheter Directed Thrombolysis As Treatment For Acute SMA Occlusion
  Presenter(s):Bjõrn Sonesson, MD, PhD / Martin Bjorck, MD, PhD / Timothy A. Resch, MD, PhD  
5:26 PM - 5:30 PM Novel Endovascular Techniques For Treating Complex Iliac Aneurysmal Disease
  Presenter(s):Joseph L. Mills, MD / Luis R. Leon, MD, RVT, FACS  
5:31 PM - 5:35 PM Laparoscopic Sutureless Aortobifemoral Bypass Using The Lachat Viabahn (VORTEC) Technique
  Presenter(s):Ralf R. Kolvenbach, MD  
  View Abstract      
5:36 PM - 5:40 PM How Do Long Bare Metal SFA Stents Perform: The DURABILITY Trial Clinical Outcomes, Treadmill Data, Objective Patency, And Routine Stent Fracture Assessment
  Presenter(s):Jon S. Matsumura, MD  
5:41 PM - 5:45 PM Homocysteine Is A Predictor Of Vascular Mortality: A Useful Marker Misunderstood
  Presenter(s):Afshin Assadian, MD  
5:46 PM - 5:51 PM Use Of Duplex Ultrasound To Facilitate Distal Tibial And Pedal Access To Treat Lower Extremity Occlusive Disease
  Presenter(s):Jihad A. Mustapha, MD  
5:51 PM - 6:00 PM Panel Discussion
Conclusion of Program D.

END OF SESSION 25
previous next